Related Experiment Video
Updated: Jan 27, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
Silvia Shinpei Chiang1,2, Yana Sheremeta3, Rachel Sophie Padilla4
1Department of Pediatrics, Alpert Medical School of Brown University, Providence, RI, USA.
Insights
Pediatric Multidrug-resistant Tuberculosis (MDR-TB) in Ukraine showed excellent outcomes, with 90% of children successfully treated. This study highlights effective management strategies for pediatric MDR-TB in a high-burden region.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- The former Soviet republics have the highest proportion of Multidrug-resistant Tuberculosis (MDR-TB) cases globally.
- Limited data exists on pediatric MDR-TB in this region, particularly in Ukraine.
Purpose of the Study:
- To examine the characteristics and treatment outcomes of pediatric MDR-TB in Ukraine.
- To provide insights into managing this challenging disease in a high-burden setting.
Main Methods:
- Retrospective cohort study of children (<18 years) undergoing MDR-TB treatment in Kyiv, Ukraine (2011-2016).
- Demographic and clinical data were abstracted from medical charts.
- Fisher's exact test was used to compare confirmed vs. probable MDR-TB cases.
Main Results:
- The study included 20 children with a median age of 5 years.
- At diagnosis, 60% had intrathoracic lymphadenopathy as the sole radiographic abnormality; 10% were asymptomatic.
- Adolescents and those with additional radiologic abnormalities were more likely to have confirmed MDR-TB.
- Median treatment duration was 20 months.
- 90% of children achieved successful treatment outcomes.
Conclusions:
- Pediatric MDR-TB in Ukraine can be treated successfully, with outcomes comparable to global reports.
- Effective management strategies are crucial for improving pediatric MDR-TB outcomes in high-burden regions.
- Further research is needed to understand specific risk factors and optimize treatment protocols.
Abstract:
Few reports have described pediatric Multidrug-resistant Tuberculosis (MDR-TB) in the former Soviet republics, despite the fact that these countries have the highest proportion of TB cases that are MDR. We aimed to examine pediatric MDR-TB in Ukraine. This retrospective cohort study included all children <18 years of age who started undergoing MDR-TB treatment between January 1, 2011 and July 31, 2016 at Kyiv City Pediatric TB Hospital. From each child's clinical chart, we abstracted demographic and clinical data. Using Fisher's exact test, we compared characteristics between children with microbiologically confirmed vs. probable (i.e., clinically diagnosed) MDR-TB. The study population included 20 children with a median age of 5 years. At diagnosis, 12 (60%) had intrathoracic lymphadenopathy as their only radiographic abnormality, and two (10%) were asymptomatic. Children with confirmed MDR-TB were more likely to be adolescents or have radiologic abnormalities in addition to intrathoracic lymphadenopathy. Median treatment duration was 20 months. Eighteen (90%) children were treated successfully. The remaining two were transferred to another facility, and their final outcomes were unknown. The excellent outcomes in this cohort are consistent with high treatment success rates for pediatric MDR-TB reported in other parts of the world.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
07:35Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Resistivity
Resistance
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: